However, the drug resistance of cancer cells was significantly reduced while downregulating the expression of GPx4, suggesting that GPx4 may reduce the sensitivity of cancer cells to radiotherapy and chemotherapy by regulating the intracellular oxidation level of tumour cells. This evidence concerns the gene GPX4 and cancer.